Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. Exciting news for the peptide world making these peptides easier to prescribe and likely dropping the prices for them. As always know your prescriber and avoid the gray market due to unregulated A large number of peptides currently being marketed to the public are not FDA approved. These include BPC 157, LL 37, DSIP, Epitalon, GHK Cu (injectable), GHRP 2, GHRP 6, ipamorelin, kisspeptin 10, KPV, melanotan II, PEG MGF, MOTS C, Peptide Injections: What They Are, What They Promise, and the Big Unknowns